Ouyang et al. [31] found that miR-130-3p was down-regulated in triple-negative breast cancer (TNBC) compared with matched peritumoral counterparts; Ottley et al. [32] observed that miR-130-3p significantly decreased in activin-sensitive prostate cancer (LNCaP) cells; and Snyder-Talkington et al. [33] claimed that miR-130-3p was down-regulated in bronchioloalveolar adenocarcinoma. The gene discussed is INHBE; the disease is triple-negative breast carcinoma.